DOYLE THOMAS JAMES
SVP, Finance & Accounting
DOYLE THOMAS JAMES has filed 4 SEC Form 4 filings (10 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Jan 27, 2026.
On the most recent filing, DOYLE THOMAS JAMES is listed as SVP, Finance & Accounting at Kura Oncology, Inc. Inside the rolling window, DOYLE THOMAS JAMES reported no open-market purchases and 3 open-market sales totaling $133K in KURA. The largest disclosed transaction in the window is a sale of 4,539 KURA shares on Nov 14, 2025, worth $51K.
Companies traded
Other insiders at KURA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$133K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has DOYLE THOMAS JAMES made?
DOYLE THOMAS JAMES has filed 4 SEC Form 4 filings (10 transaction rows) across 1 company since 2025.
Which companies does DOYLE THOMAS JAMES trade?
DOYLE THOMAS JAMES has filed SEC Form 4 disclosures for 1 company, including KURA.
When was DOYLE THOMAS JAMES's most recent SEC Form 4 filing?
DOYLE THOMAS JAMES's most recent SEC Form 4 filing on Tracefour is dated Jan 27, 2026.
What is DOYLE THOMAS JAMES's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, DOYLE THOMAS JAMES is listed as SVP, Finance & Accounting.
What is DOYLE THOMAS JAMES's total buy and sell value in the current window?
Inside the rolling retention window, DOYLE THOMAS JAMES bought $0 and sold $133K based on SEC Form 4 filings.
What was DOYLE THOMAS JAMES's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 4,539 KURA shares on 2025-11-14, worth $51K, per SEC Form 4 filings.